AU2002227496A1 - Polynucleotides and polypeptides - Google Patents

Polynucleotides and polypeptides

Info

Publication number
AU2002227496A1
AU2002227496A1 AU2002227496A AU2749602A AU2002227496A1 AU 2002227496 A1 AU2002227496 A1 AU 2002227496A1 AU 2002227496 A AU2002227496 A AU 2002227496A AU 2749602 A AU2749602 A AU 2749602A AU 2002227496 A1 AU2002227496 A1 AU 2002227496A1
Authority
AU
Australia
Prior art keywords
polynucleotides
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002227496A
Inventor
Ian Mcdonald Hayes
Raymond Anthony Jupp
William Kenneth Pollack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis UK Holdings Ltd
Original Assignee
Aventis Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0018700A external-priority patent/GB0018700D0/en
Application filed by Aventis Pharma Ltd filed Critical Aventis Pharma Ltd
Publication of AU2002227496A1 publication Critical patent/AU2002227496A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002227496A 2000-07-31 2001-07-30 Polynucleotides and polypeptides Abandoned AU2002227496A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0018700A GB0018700D0 (en) 2000-07-31 2000-07-31 Polynucleotides and polypeptides
GB0018700.5 2000-07-31
GB0031021.9 2000-12-19
GB0031021A GB0031021D0 (en) 2000-07-31 2000-12-19 Polynucleotides and polypeptides
PCT/GB2001/003390 WO2002010198A2 (en) 2000-07-31 2001-07-30 Polynucleotides and polypeptides

Publications (1)

Publication Number Publication Date
AU2002227496A1 true AU2002227496A1 (en) 2002-02-13

Family

ID=26244763

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002227496A Abandoned AU2002227496A1 (en) 2000-07-31 2001-07-30 Polynucleotides and polypeptides
AU2002227496A Abandoned AU2002227496A8 (en) 2000-07-31 2001-07-30 Polynucleotides and polypeptides

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2002227496A Abandoned AU2002227496A8 (en) 2000-07-31 2001-07-30 Polynucleotides and polypeptides

Country Status (3)

Country Link
AU (2) AU2002227496A1 (en)
GB (1) GB0031021D0 (en)
WO (1) WO2002010198A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1313850B1 (en) 2000-08-28 2008-08-06 Agensys, Inc. Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer
WO2021248053A2 (en) * 2020-06-04 2021-12-09 Godx, Inc. Point-of-care sars-cov-2 virus diagnostic device and methods of use thereof

Also Published As

Publication number Publication date
AU2002227496A8 (en) 2007-12-20
WO2002010198A3 (en) 2007-10-18
WO2002010198A2 (en) 2002-02-07
GB0031021D0 (en) 2001-01-31

Similar Documents

Publication Publication Date Title
AUPQ976800A0 (en) Novel polypeptides and polynucleotides and uses therefor
AU2002252705A1 (en) Polynucleotides and polypeptides associated with the nf-kb pathway
AU2001265009A1 (en) Human polynucleotides and polypeptides encoded thereby
IL153568A (en) Novel polypeptides and polynucleotides
AU5043200A (en) Adam polynucleotides and polypeptides
EP1409661A4 (en) Hdac9 polypeptides and polynucleotides and uses thereof
AU2001280608A1 (en) Human polynucleotides and polypeptides encoded thereby
AU2002330672A1 (en) Gmg-1 polynucleotides and polypeptides and uses thereof
AU4001000A (en) Dwf4 polynucleotides, polypeptides and uses thereof
AU2001238585A1 (en) Human polynucleotides, polypeptides, and antibodies
AU2001240075A1 (en) Full length expressed polynucleotides and the polypeptides they encode
AU4273099A (en) Polypeptides, polynucleotides and uses thereof
AU2001288220A1 (en) Hyperglycosylated polypeptides
AU2001255832A1 (en) Orfx polynucleotides and polypeptides
GB9917165D0 (en) Polypeptides polynuclcotides and uses thereof
AU2002227496A1 (en) Polynucleotides and polypeptides
AU2002218199A1 (en) Truncated phosphodiesterase-7 polypeptides
AU2001294267A1 (en) Survivin-like polypeptides and dnas thereof
AU2001229517A1 (en) Human polynucleotides, polypeptides, and antibodies
AUPQ645700A0 (en) Novel polypeptides and polynucleotides and methods of using them
AU6712600A (en) Polypeptides
AU1228201A (en) Umlr polypeptides
AU2002305055A1 (en) T-cell polynucleotides and polypeptides
AU2002251433A1 (en) Gssp3 polynucleotides and polypeptides and uses thereof
AUPR027700A0 (en) Novel polynucleotides and polypeptides and uses therefor